Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 14Unknown 3Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 2Gastroesophageal Reflux 1Gastritis 1Esophagitis 1Drug-Related Side Effects and Adverse Reactions 1Barrett Esophagus 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Bevacizumab 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Esomeprazole × Gastrointestinal × Clear all
NCT06216639 2024-02-09

Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection

National Institute of Public Health, Slovenia

Unknown
2,000 enrolled
Gastrointestinal

Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT05100446 2021-10-29

Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection

Unidade Local de Saúde do Alto Ave, EPE

Phase EARLY_PHASE1 Unknown
100 enrolled
Gastrointestinal

Gastritis, Stomach Neoplasms

NCT00216788 2010-03-16

The Effect of Nexium on Transmucosal Esophageal Leak

Main Line Health

Phase 1 Unknown
35 enrolled
Gastrointestinal

Barrett Esophagus, Esophagitis, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡